DVAX
Income statement / Annual
Last year (2024), Dynavax Technologies Corporation's total revenue was $277.25 M,
an increase of 19.36% from the previous year.
In 2024, Dynavax Technologies Corporation's net income was $27.31 M.
See Dynavax Technologies Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$277.25 M |
$232.28 M |
$722.68 M |
$439.44 M |
$46.55 M |
$35.22 M |
$8.20 M |
$327,000.00 |
$11.04 M |
$4.05 M |
| Cost of Revenue |
$0.00
|
$50.17 M
|
$262.15 M
|
$173.57 M
|
$13.91 M
|
$19.39 M
|
$21.80 M
|
$1.19 M
|
$0.00
|
$0.00
|
| Gross Profit |
$277.25 M
|
$182.12 M
|
$460.53 M
|
$265.87 M
|
$32.64 M
|
$15.83 M
|
-$13.60 M
|
-$867,000.00
|
$11.04 M
|
$4.05 M
|
| Gross Profit Ratio |
1
|
0.78
|
0.64
|
0.61
|
0.7
|
0.45
|
-1.66
|
-2.65
|
1
|
1
|
| Research and Development Expenses |
$61.55 M
|
$54.89 M
|
$46.60 M
|
$32.23 M
|
$28.61 M
|
$62.33 M
|
$74.95 M
|
$64.99 M
|
$84.49 M
|
$86.94 M
|
| General & Administrative Expenses |
$170.37 M
|
$152.95 M
|
$131.41 M
|
$100.16 M
|
$79.26 M
|
$48.72 M
|
$64.77 M
|
$27.37 M
|
$37.26 M
|
$22.18 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$24.76 M
|
$26.27 M
|
$31.76 M
|
$7.61 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$170.37 M
|
$152.95 M
|
$131.41 M
|
$100.16 M
|
$79.26 M
|
$74.99 M
|
$64.77 M
|
$27.37 M
|
$37.26 M
|
$22.18 M
|
| Other Expenses |
$49.45 M
|
$11.31 M
|
$7.80 M
|
$8.66 M
|
$6.81 M
|
$3.35 M
|
-$70,000.00
|
-$486,000.00
|
-$2.49 M
|
$317,000.00
|
| Operating Expenses |
$281.37 M
|
$219.15 M
|
$178.01 M
|
$132.38 M
|
$107.86 M
|
$137.32 M
|
$139.72 M
|
$93.55 M
|
$121.75 M
|
$109.12 M
|
| Cost And Expenses |
$281.37 M
|
$269.31 M
|
$440.16 M
|
$305.96 M
|
$121.77 M
|
$156.71 M
|
$161.52 M
|
$93.55 M
|
$121.75 M
|
$109.12 M
|
| Interest Income |
$36.46 M
|
$31.99 M
|
$7.91 M
|
$140,000.00
|
$1.26 M
|
$3.37 M
|
$3.83 M
|
$1.34 M
|
$755,000.00
|
$205,000.00
|
| Interest Expense |
$6.79 M
|
$6.76 M
|
$6.73 M
|
$11.18 M
|
$19.06 M
|
$16.98 M
|
$9.34 M
|
$0.00
|
$0.00
|
$572,000.00
|
| Depreciation & Amortization |
$8.05 M
|
$7.28 M
|
$6.67 M
|
$7.01 M
|
$9.34 M
|
$21.53 M
|
$14.48 M
|
$4.44 M
|
$2.26 M
|
$1.37 M
|
| EBITDA |
$45.70 M |
$9.67 M |
$307.70 M |
$95.71 M |
-$46.84 M |
-$114.09 M |
-$135.08 M |
-$90.72 M |
-$110.19 M |
-$104.86 M |
| EBITDA Ratio |
0.16
|
0.04
|
0.41
|
0.32
|
-1.44
|
-3.26
|
-18.24
|
-272.92
|
-10.03
|
-25.82
|
| Operating Income Ratio |
-0.01
|
-0.16
|
0.39
|
0.31
|
-1.62
|
-3.45
|
-18.7
|
-293.59
|
-10.03
|
-25.94
|
| Total Other Income/Expenses Net |
$34.98 M
|
$32.66 M
|
$10.78 M
|
-$56.97 M
|
-$6.87 M
|
-$17.76 M
|
-$5.58 M
|
$851,000.00
|
-$1.74 M
|
-$1.72 M
|
| Income Before Tax |
$30.86 M
|
-$4.37 M
|
$294.30 M
|
$77.52 M
|
-$75.24 M
|
-$152.60 M
|
-$158.90 M
|
-$95.15 M
|
-$112.44 M
|
-$106.79 M
|
| Income Before Tax Ratio |
0.11
|
-0.02
|
0.41
|
0.18
|
-1.62
|
-4.33
|
-19.38
|
-290.99
|
-10.18
|
-26.37
|
| Income Tax Expense |
$3.55 M
|
$2.02 M
|
$1.14 M
|
$808,000.00
|
$16.54 M
|
-$1.20 M
|
$3.76 M
|
$1.45 M
|
-$3.01 M
|
-$476,000.00
|
| Net Income |
$27.31 M
|
-$6.39 M
|
$293.16 M
|
$76.71 M
|
-$91.78 M
|
-$151.40 M
|
-$158.90 M
|
-$95.15 M
|
-$112.44 M
|
-$106.79 M
|
| Net Income Ratio |
0.1
|
-0.03
|
0.41
|
0.17
|
-1.97
|
-4.3
|
-19.38
|
-290.99
|
-10.18
|
-26.37
|
| EPS |
0.21 |
-0.0496 |
2.32 |
0.62 |
-0.91 |
-2.1 |
-2.55 |
-1.81 |
-2.92 |
-3.25 |
| EPS Diluted |
0.2 |
-0.0496 |
1.97 |
0.54 |
-0.91 |
-2.1 |
-2.55 |
-1.81 |
-2.92 |
-3.25 |
| Weighted Average Shares Out |
$130.05 M
|
$128.73 M
|
$126.40 M
|
$116.26 M
|
$100.75 M
|
$72.02 M
|
$62.36 M
|
$52.61 M
|
$38.51 M
|
$32.88 M
|
| Weighted Average Shares Out Diluted |
$133.34 M
|
$128.73 M
|
$150.80 M
|
$133.01 M
|
$100.75 M
|
$72.02 M
|
$62.36 M
|
$52.61 M
|
$38.51 M
|
$32.88 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
